| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008204853 |
| P356 | DOI | 10.1007/BF00634451 |
| P698 | PubMed publication ID | 2528779 |
| P2093 | author name string | P C Moser | |
| P2860 | cites work | A simple and reliable conflict procedure for testing anti-anxiety agents | Q70564912 |
| Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug | Q72569245 | ||
| Determinants of emotionality in the rat. I. Situational factors | Q74447234 | ||
| Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 | ||
| Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons | Q34683390 | ||
| Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes | Q34683834 | ||
| Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic | Q39459903 | ||
| Relationships between exploratory behaviour and fear: a review | Q39932424 | ||
| Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors | Q42208682 | ||
| MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptors | Q43910621 | ||
| Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. | Q45736709 | ||
| Ipsapirone depresses neuronal activity in the dorsal raphe nucleus and the hippocampal formation | Q48288246 | ||
| Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug | Q48299256 | ||
| (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists | Q48300462 | ||
| Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors | Q48436884 | ||
| Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors | Q48460153 | ||
| 3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic | Q48532640 | ||
| A method for measuring monoamine turnover in animals using an irreversible inhibitor of aromatic L-amino acid decarboxylase, DL-α-mono fluoromethyldopa | Q48653773 | ||
| Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. | Q48662052 | ||
| Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour | Q49012982 | ||
| Autonomic and psychic effects of yohimbine hydrochloride | Q61535048 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | elevated plus maze | Q5359685 |
| P304 | page(s) | 48-53 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone | |
| P478 | volume | 99 |
| Q33856568 | 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review |
| Q40457638 | 5-Hydroxytryptamine pathways in anxiety and its treatment |
| Q40465103 | 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research |
| Q40601511 | 5HT drugs in animal models of anxiety |
| Q42708483 | A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat. |
| Q34344347 | Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions |
| Q34212545 | Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein |
| Q68245348 | An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice |
| Q36511808 | Animal models of anxiety and the development of novel anxiolytic drugs |
| Q41552526 | Animal models of anxiety: an ethological perspective |
| Q37591747 | Animal models of drug withdrawal symptoms |
| Q48359189 | Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat. |
| Q51172671 | Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. |
| Q41672220 | Anxiety, defence and the elevated plus-maze |
| Q51156353 | Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: Reversal by buspirone |
| Q42627887 | Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice |
| Q48149826 | Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides |
| Q28370332 | Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia |
| Q44424590 | Anxiolytic Effect of Ting-Chih-Wan in Mouse Behavior Models of Anxiety |
| Q42644833 | Anxiolytic and anticonvulsant properties of doramectin in rats: behavioral and neurochemistric evaluations |
| Q30479172 | Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils |
| Q42690200 | Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. |
| Q36649289 | Benzodiazepines, putative anxiolytics and animal models of anxiety |
| Q50734525 | CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. |
| Q24673597 | Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam |
| Q42610690 | Chemical composition of the essential oil from kelussia odoratissima Mozaff. and the evaluation of its sedative and anxiolytic effects in mice |
| Q36962703 | Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour? |
| Q42663773 | Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze |
| Q44025232 | Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze |
| Q48286591 | Differential behavioral effects of TFF peptides: injections of synthetic TFF3 into the rat amygdala |
| Q51677229 | Discriminative stimulus properties of a new anxiolytic, DN-2327, in rats. |
| Q42609726 | Dissociation of the effects of ethanol on memory, anxiety, and motor behavior in mice tested in the plus-maze discriminative avoidance task |
| Q48825795 | Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics |
| Q48594691 | Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection |
| Q44308063 | Effect of the serotonin agonist buspirone on behaviour and hypothalamic-pituitary-adrenal axis in confident and fearful mink |
| Q48882349 | Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze |
| Q44403918 | Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice |
| Q42618095 | Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience |
| Q48786897 | Effects of early postnatal handling on brain β-adrenoceptors and behavior in tests related to stress |
| Q46845794 | Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning. |
| Q51085423 | Effects of rolipram on the elevated plus-maze test in rats: a preliminary study. |
| Q51131200 | Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT. |
| Q48618261 | Effects of weekly or daily exposure to the elevated plus-maze in male mice |
| Q37600530 | Enhancing Spatial Memory: Anxiolytic and Antidepressant Effects of Tapinanthus dodoneifolius (DC) Danser in Mice |
| Q51136059 | Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. |
| Q35740489 | Evaluation of anxiolytic activity of aqueous extract of Coriandrum sativum Linn. in mice: A preliminary experimental study |
| Q34317911 | Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety |
| Q52209292 | Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. |
| Q30444307 | Exploring the role of 5-HT1A receptors in the regulation of prepulse inhibition in mice: implications for cross-species comparisons |
| Q43562513 | Involvement of the GABAA/benzodiazepine chloride ionophore receptor complex in the 5,7-DHT induced anticonflict effect |
| Q34037757 | Long-lasting anxiolytic effect of neural precursor cells freshly prepared but not neurosphere-derived cell transplantation in newborn rats |
| Q51716529 | NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations |
| Q48120994 | Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. |
| Q51126863 | Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice. |
| Q52193324 | Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. |
| Q48703613 | Structure of the mouse behaviour on the elevated plus-maze test of anxiety |
| Q33963310 | The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze. |
| Q43722642 | The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism |
| Q42657606 | The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat. |
| Q35992510 | The olfactory hole-board test in rats: a new paradigm to study aversion and preferences to odors. |
| Q54017665 | The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models. |
| Q48712997 | The relation between skin conductance level and plus-maze behavior in male mice |
| Q42687862 | The role of vision and proprioception in the aversion of rats to the open arms of an elevated plus-maze |
| Q40532095 | Use of the elevated plus maze in the search for novel anxiolytic agents |
| Q42689637 | Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety |
| Q48678690 | Vibrissal sense is not the main sensory modality in rat exploratory behavior in the elevated plus-maze |
Search more.